This inventor holds 157 USPTO granted patents and 52 published patent applications, plus 10 CIPO patents and 27 EPO patents, primarily in Pharmaceutical Formulations (CPC class A61K31-485). Top assignees: Purdue Pharma L.p., Euro-Celtique S.a., Purdue Pharmaceuticals L.p.. Active years: 1984-2021.
Inventors with similar research interests:
Location History:
- New York, NY (US) (1984 - 2019)
- Boca Raton, FL (US) (2013 - 2021)
Company Filing History:
118 out of 547 
39 out of 270 
32 out of 77 
Years Active: 1984-2021
Areas of Expertise:
Title: Benjamin Oshlack: Prolific Inventor in Pharmaceutical Formulations
Introduction: Benjamin Oshlack, a renowned inventor based in Boca Raton, Florida, has made significant contributions in the field of pharmaceutical formulations. With an impressive portfolio of 157 patents, Oshlack has revolutionized drug delivery systems, particularly in controlled-release dosage forms.
Latest Patents: Among his latest patents is a groundbreaking pharmaceutical formulation containing a gelling agent. This controlled-release oral dosage form is designed to provide a therapeutic effect for at least 12 hours when orally administered to patients, offering a solution for drugs susceptible to abuse. Additionally, Oshlack's oxycodone formulations focus on sustained-release formulations with specific C/Coxycodone ratios after oral administration.
Career Highlights: Oshlack has made substantial impacts while working with leading pharmaceutical companies such as Purdue Pharma L.P. and Euro-Celtique S.A. His expertise and innovative approach have led to the development of novel drug delivery systems that enhance patient outcomes and safety.
Collaborations: Throughout his career, Oshlack has collaborated with esteemed professionals in the industry, including Curtis Wright and Hua-Pin Huang. These collaborations have further enriched his inventive process and contributed to the success of his patented technologies.
Conclusion: Benjamin Oshlack's prolific career as an inventor in pharmaceutical formulations showcases his commitment to advancing healthcare solutions through innovative drug delivery systems. His patents stand as a testament to his dedication to improving patient care and pharmaceutical efficacy in the industry.